Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes

NCT07055516 is registered in ClinicalTrials.gov with Rezera (formerly NodThera Limited) as lead sponsor.

NCT NCT07055516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07055516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes
Lead sponsor
Rezera (formerly NodThera Limited)
Phase
Phase 2
Overall status
Completed
Start date
May 8, 2025
Completion date
May 27, 2026
Enrollment
176 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

obesity and type 2 diabetes